461 related articles for article (PubMed ID: 18466428)
1. Differentiation of EBV-induced post-transplant Hodgkin lymphoma from Hodgkin-like post-transplant lymphoproliferative disease.
Rohr JC; Wagner HJ; Lauten M; Wacker HH; Jüttner E; Hanke C; Pohl M; Niemeyer CM
Pediatr Transplant; 2008 Jun; 12(4):426-31. PubMed ID: 18466428
[TBL] [Abstract][Full Text] [Related]
2. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
Hurwitz M; Desai DM; Cox KL; Berquist WE; Esquivel CO; Millan MT
Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
[TBL] [Abstract][Full Text] [Related]
3. Hodgkin's lymphoma after post-transplant lymphoproliferative disease in a renal transplant recipient.
Dharnidharka VR; Douglas VK; Hunger SP; Fennell RS
Pediatr Transplant; 2004 Feb; 8(1):87-90. PubMed ID: 15009846
[TBL] [Abstract][Full Text] [Related]
4. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
Knight JS; Tsodikov A; Cibrik DM; Ross CW; Kaminski MS; Blayney DW
J Clin Oncol; 2009 Jul; 27(20):3354-62. PubMed ID: 19451438
[TBL] [Abstract][Full Text] [Related]
5. [Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center].
Franco A; Jiménez L; Aranda I; Alvarez L; González M; Rocamora N; Olivares J
Nefrologia; 2002; 22(5):463-9. PubMed ID: 12497748
[TBL] [Abstract][Full Text] [Related]
6. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
[TBL] [Abstract][Full Text] [Related]
7. EBV-associated recurrent Hodgkin's disease after renal transplantation.
Flanagan KH; Brennan DC
Transpl Int; 2006 Apr; 19(4):338-41. PubMed ID: 16573551
[TBL] [Abstract][Full Text] [Related]
8. Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real-time PCR light cycler.
Leung E; Shenton BK; Green K; Jackson G; Gould FK; Yap C; Talbot D
Transpl Infect Dis; 2004 Dec; 6(4):156-64. PubMed ID: 15762933
[TBL] [Abstract][Full Text] [Related]
9. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
[TBL] [Abstract][Full Text] [Related]
10. A case of post-transplant lymphoproliferative disease presenting as CD20-expressing, Epstein-Barr-virus positive Hodgkin lymphoma.
Stern M; Herrmann R; Rochlitz C; Dirnhofer S; Pless M
Eur J Haematol; 2005 Mar; 74(3):267-70. PubMed ID: 15693799
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus (EBV)-positive lymphoproliferations in post-transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes.
Bräuninger A; Spieker T; Mottok A; Baur AS; Küppers R; Hansmann ML
Eur J Immunol; 2003 Jun; 33(6):1593-602. PubMed ID: 12778477
[TBL] [Abstract][Full Text] [Related]
12. Management and outcome of liver recipients with post-transplant lymphoproliferative disease.
Glez-Chamorro A; Jimenez C; Moreno-Glez E; Glez-Pinto I; Loinaz C; Gomez R; Garcia I; Alonso O; Palma F; Grande C
Hepatogastroenterology; 2000; 47(31):211-9. PubMed ID: 10690611
[TBL] [Abstract][Full Text] [Related]
13. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].
Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E
Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676
[TBL] [Abstract][Full Text] [Related]
14. Severe cold agglutinin disease caused by recurrent monomorphic Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorder (PTLD), clonally related to an EBV-negative plasmacytic hyperplasia in a pediatric multivisceral organ transplant recipient.
Brunner B; Kropshofer G; Ellemunter H; Brunner A; Mueller T; Margreiter R; Tzankov A
Pediatr Transplant; 2007 Aug; 11(5):547-51. PubMed ID: 17631026
[TBL] [Abstract][Full Text] [Related]
15. Low viral load post-transplant lymphoproliferative disease localized within the tongue.
Henry DD; Hunger SP; Braylan RC; Dharnidharka VR
Transpl Infect Dis; 2008 Dec; 10(6):426-30. PubMed ID: 18657087
[TBL] [Abstract][Full Text] [Related]
16. Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease.
Meerbach A; Wutzler P; Häfer R; Zintl F; Gruhn B
J Med Virol; 2008 Mar; 80(3):441-54. PubMed ID: 18205222
[TBL] [Abstract][Full Text] [Related]
17. Benign and malignant Epstein-Barr virus-associated B-cell lymphoproliferative diseases.
Cohen JI
Semin Hematol; 2003 Apr; 40(2):116-23. PubMed ID: 12704588
[TBL] [Abstract][Full Text] [Related]
18. The contribution of the Epstein-Barr virus to the pathogenesis of childhood lymphomas.
Cader FZ; Kearns P; Young L; Murray P; Vockerodt M
Cancer Treat Rev; 2010 Jun; 36(4):348-53. PubMed ID: 20193983
[TBL] [Abstract][Full Text] [Related]
19. Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment.
Guthery SL; Heubi JE; Bucuvalas JC; Gross TG; Ryckman FC; Alonso MH; Balistreri WF; Hornung RW
Transplantation; 2003 Apr; 75(7):987-93. PubMed ID: 12698085
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course.
Oertel S; Trappe RU; Zeidler K; Babel N; Reinke P; Hummel M; Jonas S; Papp-Vary M; Subklewe M; Dörken B; Riess H; Gärtner B
Ann Hematol; 2006 Jul; 85(7):478-84. PubMed ID: 16586109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
